Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NW-3509A in Chronic Schizophrenia
NCT02624167Phase 2Completed
- Sponsor
- Newron Pharmaceuticals
- Start
- Dec 2015
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of evenamide in schizophrenia, sponsored by Newron Pharmaceuticals. Started Dec 2015; status: completed.
02
Drugs
evenamide
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT02624167.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02624167.